Insomnia´s Impact on DNA Stability, Cardio-metabolic Health and Lifestyle Behaviors

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorUniversidad Autonoma de Baja California

About this trial

Insomnia is a highly prevalent sleep disorder worldwide, with an increasing incidence in athletes, older adults, university students, and individuals with metabolic syndrome. This disorder has been associated with metabolic dysfunction, cardiovascular diseases, and genetic instability. Recent evidence suggests that insomnia negatively impacts cardiorespiratory fitness, insulin sensitivity, and overall health through mechanisms involving neuroendocrine dysregulation, oxidative stress, and alterations in energy metabolism. However, the specific biological and environmental factors that contribute to its prevalence and health consequences remain poorly understood, particularly across different populations. Understanding these associations is crucial for developing effective prevention and intervention strategies to mitigate the long-term impact of insomnia. Therefore, this study aims to analyze the impact of insomnia on body composition, cardiorespiratory fitness, metabolic flexibility, and DNA integrity, across populations with high prevalence of insomnia, including athletes, older adults, university students, and individuals with metabolic syndrome. This study will also investigate which biological and lifestyle behaviors contribute to insomnia and its health consequences. By doing so, this work will provide critical insights into the physiological and molecular mechanisms that link insomnia with metabolic and cardiovascular dysfunction, contributing to the development of targeted interventions for at-risk populations

Eligibility criteria

Qualifiers

Healthy Individuals (18-35 years old, men and women)

Waist circumference: <90 cm (men), <80 cm (women)

Fasting glucose: 70-110 mg/dL

Blood pressure: <120/80 mmHg

Disqualifiers

Individuals with respiratory diseases or musculoskeletal injuries that prevent exercise, as determined by a clinical history review, a physical activity readiness questionnaire (PART-Q+), and pulmonary function tests (spirometry).

Women diagnosed with polycystic ovary syndrome (PCOS) or showing high testosterone levels with a history of oligomenorrhea, as these conditions may influence metabolic and hormonal markers. However, women with menstrual irregularities related to premenstrual syndrome (PMS) or dysmenorrhea will not be excluded, given the established link between sleep disorders and menstrual cycle variations

This study does not involve chronic dietary or exercise interventions, nor does it require long-term participant follow-up, so no additional exclusion criteria apply

Trial design

Treatments tested in this trial

  • Exercise
  • Bioelectrical Impedance
  • Micronucleus Assay
  • Physical activity and sedentary time
  • Sleep
  • blood sampling
  • psychometrics
  • Nutritional Supplement
  • Genotyping

Treatment groups

300 Participants
are divided into 5 treatment groups

Sponsors and collaborators

Universidad Autonoma de Baja California

Lead sponsor

Universidad de Granada

Collaborator

University of Colorado, Denver

Collaborator

Instituto Nacional de Salud Publica, Mexico

Collaborator